Gemfibrozil Tablet
Product Images NDC 71209-008

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Gemfibrozil (NDC 71209-008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cadila Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gem-600mg-180tabs (Gem 600mg 180tabs)

Label for Gemfibrozil Tablets USP 600 mg, oral tablets manufactured by Cadila Pharmaceuticals Limited. The label states each film-coated tablet contains 600 mg gemfibrozil, with storage instructions and usual dosage reference. The package contains 180 tablets and includes a barcode and NDC 71209-008-08.*

FDA Label Image

Gem-600mg-500tabs (Gem 600mg 500tabs)

Label for Gemfibrozil Tablets, USP 600 mg by Cadila Pharmaceuticals Limited. The label indicates 500 tablets per container, oral dosage form, and prescription use only. It includes storage instructions and manufacturer details, along with an NDC barcode 71209-008-10.*

FDA Label Image

Gem-600mg-60tabs (Gem 600mg 60tabs)

Label for Gemfibrozil Tablets, USP 600 mg by Cadila Pharmaceuticals Limited. The label indicates 60 tablets per container, with storage instructions at controlled room temperature (20°-25°C), protection from light and humidity, and dispensing in a tight container. It includes a barcode and a note about serialization datamatrix code and batch coding space.*

FDA Label Image

Gem-structure (Gem Structure)

Chemical structure diagram of Gemfibrozil, illustrating its molecular arrangement with methyl groups, an ether linkage, and a carboxylic acid functional group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.